Market Place
Sourcing Support
Gritstone files for bankruptcy in hope of keeping R&D afloat
11 Oct 2024 //
BIOSPACE
Gritstone Bio To Host KOL Event On GRANITE For MSS-CRC
24 Jul 2024 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Jul 2024 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 Jun 2024 //
GLOBENEWSWIRE
Gritstone Q1 2024 Results, Corporate Updates On May 9
02 May 2024 //
GLOBENEWSWIRE
Gritstone bio Presents Improvements to EDGE Platform at AACR 2024
08 Apr 2024 //
GLOBENEWSWIRE
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results
05 Mar 2024 //
GLOBENEWSWIRE
Gritstone bio Announces Workforce Reduction
29 Feb 2024 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Dec 2023 //
GLOBENEWSWIRE
Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results
09 Mar 2023 //
GLOBENEWSWIRE
Gritstone bio to Report Fourth Quarter and Full Year 2022 Financial Results
02 Mar 2023 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
27 Feb 2023 //
GLOBENEWSWIRE
Gritstone bio to Participate in 43rd Annual Cowen Healthcare Conference
27 Feb 2023 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 Jan 2023 //
GLOBENEWSWIRE
Gritstone bio to Participate in Upcoming Investor Conferences
18 Jan 2023 //
GLOBENEWSWIRE
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 Dec 2022 //
GLOBENEWSWIRE
Gritstone bio to Present at 41st Annual J.P. Morgan Healthcare Conference
15 Dec 2022 //
GLOBENEWSWIRE
Gritstone bio Granted Two New U.S. Patents for Self-amplifying mRNA (samRNA)
13 Dec 2022 //
GLOBENEWSWIRE
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
21 Nov 2022 //
GLOBENEWSWIRE
Gritstone Announces Updated Overall Survival Results from GRANITE Ph 1/2 Study
10 Nov 2022 //
GLOBENEWSWIRE
Gritstone Reports 3Q FYR and Provides Business Update
03 Nov 2022 //
GLOBENEWSWIRE
Gritstone Presents Positive Results from Two Phase 1 CORAL Studies
25 Oct 2022 //
GLOBENEWSWIRE
Gritstone bio Announces Private Placement of $45.0 Million
25 Oct 2022 //
GLOBENEWSWIRE
Gritstone secures PIPE financing as it unveils PhI data for vaccine candidate
25 Oct 2022 //
ENDPTS
Gritstone to Host Data Update on CORAL and Discuss the Application of mRNA
19 Oct 2022 //
GLOBENEWSWIRE
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 Oct 2022 //
GLOBENEWSWIRE
My Biggest Worry About Gilead Sciences
14 Sep 2022 //
FOOL
Gritstone Presents Positive Initial Phase 2 Data in Late-Line Solid Tumor
12 Sep 2022 //
GLOBENEWSWIRE
Gritstone to Participate in Two Upcoming Investor Conferences
01 Sep 2022 //
GLOBENEWSWIRE
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 Aug 2022 //
GLOBENEWSWIRE
Nature Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of GRANITE
15 Aug 2022 //
GLOBENEWSWIRE
Gritstone Appoints Lawrence “Larry” Corey to its Board of Directors
10 Aug 2022 //
GLOBENEWSWIRE
Gritstone Appoints Dr. Lawrence “Larry” Corey to its Board of Directors
10 Aug 2022 //
GLOBENEWSWIRE
Gritstone Reports Second Quarter 2022 Financial Results
04 Aug 2022 //
GLOBENEWSWIRE
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
26 Jul 2022 //
GLOBENEWSWIRE
Gritstone goes the credit facility route, securing $80M
22 Jul 2022 //
ENDPTS
Gritstone to Report Second Q 2022 Financial Results & Provide Corporate Update
21 Jul 2022 //
GLOBENEWSWIRE
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Jul 2022 //
GLOBENEWSWIRE
Gritstone Announces Results from Preclinical Study of its samRNA Vaccine
10 Jun 2022 //
GLOBENEWSWIRE
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 Jun 2022 //
GLOBENEWSWIRE
Gritstone`s Updated Overall Survival Results in Advanced Colorectal Cancer
31 May 2022 //
GLOBENEWSWIRE
Gritstone to Participate in H.C. Wainwright Global Investment Conference
17 May 2022 //
GLOBENEWSWIRE
CORRECTION -- Gritstone Reports First Quarter 2022 Financial Results
06 May 2022 //
GLOBENEWSWIRE
Gritstone Reports First Quarter 2022 Financial Results
05 May 2022 //
GLOBENEWSWIRE
Gritstone to Release First Quarter 2022 Financial Results
02 May 2022 //
GLOBENEWSWIRE
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
27 Apr 2022 //
GLOBENEWSWIRE
Gritstone Presentations at AACR Further Support Expertise in Neoantigen Vaccine
12 Apr 2022 //
GLOBENEWSWIRE
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30 Mar 2022 //
GLOBENEWSWIRE
Gritstone Reports Q4 2021 and FY 2021 Financial Resultss
10 Mar 2022 //
GLOBENEWSWIRE
Gritstone says 3 Presentations for TSNA Oncology Programs at the 2022 AACR
08 Mar 2022 //
GLOBENEWSWIRE
Gritstone to Participate in Cowen 42nd Annual Health Care Conference
24 Feb 2022 //
GLOBENEWSWIRE
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 Feb 2022 //
GLOBENEWSWIRE
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25 Jan 2022 //
GLOBENEWSWIRE
Gritstone Begins Enrollment in Phase 2/3 Trial for Neoantigen Vaccine GRANITE
13 Jan 2022 //
GLOBENEWSWIRE
Gritstone reports positive data from initial arm of Covid-19 vaccine trial
05 Jan 2022 //
CLINICALTRIALSARENA
Gritstone Announces Presentations during Three Upcoming Investor Conferences
30 Dec 2021 //
GLOBENEWSWIRE
Gritstone bio and CEPI extend deal to develop Omicron vaccine candidate
07 Dec 2021 //
PHARMACEUTICAL-TECHNOLOGY
The Omicron Variant of SARS-CoV-2 has Minimal Impact on the T Cell Epitopes
29 Nov 2021 //
GLOBENEWSWIRE
Gritstone Announces Presentations during Five Upcoming Investor Conferences
25 Oct 2021 //
GLOBENEWSWIRE
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 Sep 2021 //
GLOBENEWSWIRE
